Condition

Graves' Ophthalmopathy (GO) (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Immunovant Sciences GmbH (1)

Collaborator

Intervention

placebo (administered via subcutaneous injection) (1)

rvt-1401 (administered via subcutaneous injection) (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

graves' ophthalmopathy (go)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Graves' Ophthalmopathy (GO) Trial in Worldwide (RVT-1401 (Administered via subcutaneous injection), Placebo (Administered via

Terminated

Graves' Ophthalmopathy (GO)

RVT-1401 (Administered via subcutaneous injection)
Placebo (Administered via subcutaneous injection)

Beverly Hills, California
+24 more

Aug 26, 2022